IAVI and Merck Collaborate to Develop Vaccine Against SARS-CoV-2
KENILWORTH, N.J.& NEW YORK--(BUSINESS WIRE) May 26, 2020 --Merck (NYSE: MRK), known as MSD outside the United States and Canada, and IAVI, a nonprofit scientific research organization dedicated to addressing urgent, unmet global health...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials
More News: AIDS Vaccine | Canada Health | Clinical Trials | Merck | Pharmaceuticals | SARS | USA Health | Vaccines